Mylan acquires global development and marketing rights from Prayog Labs
Once approved, the product could potentially offer a fast-acting, non-addictive treatment for acute pain
PR Newswire
HERTFORDSHIRE, England and PITTSBURGH, April 11, 2018
PR Newswire
HERTFORDSHIRE, England and PITTSBURGH, April 11, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey